High-fluorescent lymphocytes are increased in patients with COVID-19.
作者信息
Wang Zhao, He Yu, Shu Huaqing, Wang Ping, Xing Hui, Zeng Xiaoqian, Tang Zhaoming
机构信息
Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
出版信息
Br J Haematol. 2020 Jul;190(2):e76-e78. doi: 10.1111/bjh.16867. Epub 2020 Jun 8.
Abstract
摘要
相似文献
1
High-fluorescent lymphocytes are increased in patients with COVID-19.新冠病毒肺炎患者中高荧光淋巴细胞增多。
Br J Haematol. 2020 Jul;190(2):e76-e78. doi: 10.1111/bjh.16867. Epub 2020 Jun 8.
2
Hematologic parameters in patients with COVID-19 infection.新型冠状病毒肺炎（COVID-19）感染患者的血液学参数
Am J Hematol. 2020 Jun;95(6):E131-E134. doi: 10.1002/ajh.25774. Epub 2020 Mar 19.
3
Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.中国武汉严重肺炎患者的临床特征。
Respiration. 2020;99(8):649-657. doi: 10.1159/000507940. Epub 2020 Aug 25.
4
The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?严重 COVID-19 患者外周血炎症细胞的潜在变化及其预测作用：一个指标？
Clin Chim Acta. 2020 Sep;508:122-129. doi: 10.1016/j.cca.2020.05.027. Epub 2020 May 14.
5
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
6
Clinical characteristics of COVID-19 patients combined with allergy.新型冠状病毒肺炎合并过敏患者的临床特征
Allergy. 2020 Sep;75(9):2405-2408. doi: 10.1111/all.14434. Epub 2020 Jun 24.
7
COVID-19 in multiple sclerosis: The Dutch experience.COVID-19 与多发性硬化症：荷兰经验。
Mult Scler. 2020 Sep;26(10):1256-1260. doi: 10.1177/1352458520942198. Epub 2020 Jul 14.
8
Decreased "WBC*LYM" was observed in SARS-CoV-2-infected patients from a fever clinic in Wuhan.在武汉一家发热门诊的新型冠状病毒感染患者中观察到“白细胞*淋巴细胞”减少。
Clin Chem Lab Med. 2020 Jun 25;58(7):1152-1155. doi: 10.1515/cclm-2020-0270.
9
Neutrophil-to-lymphocyte ratio predicts the clearance of SARS-CoV-2 RNA in mild COVID-19 patients - a retrospective analysis from Dongxihu Fangcang Hospital in Wuhan, China.中性粒细胞与淋巴细胞比值可预测轻型新型冠状病毒肺炎患者新冠病毒RNA的清除情况——来自中国武汉东西湖方舱医院的一项回顾性分析
Clin Chem Lab Med. 2020 Jul 1;58(9):e167-e170. doi: 10.1515/cclm-2020-0733. Print 2020 Aug 27.
10
Prolonged Duration of SARS-CoV-2 Viral Positivity in a Crohn's Disease Patient.一名克罗恩病患者的新冠病毒阳性持续时间延长
Inflamm Bowel Dis. 2020 Sep 18;26(10):e124. doi: 10.1093/ibd/izaa175.
引用本文的文献
1
Identifying Key Hematological and Biochemical Indicators of Disease Severity in COVID-19 and Non-COVID-19 Patients.识别新冠病毒感染患者和非新冠病毒感染患者疾病严重程度的关键血液学和生化指标
Diagnostics (Basel). 2025 May 29;15(11):1374. doi: 10.3390/diagnostics15111374.
2
Definition of the Immune Parameters Related to COVID-19 Severity.与 COVID-19 严重程度相关的免疫参数的定义。
Front Immunol. 2022 Mar 18;13:850846. doi: 10.3389/fimmu.2022.850846. eCollection 2022.
3
Diagnostic value of white blood cell parameters for COVID-19: Is there a role for HFLC and IG?白细胞参数对 COVID-19 的诊断价值：HFLC 和 IG 是否有作用？
Int J Lab Hematol. 2022 Feb;44(1):104-111. doi: 10.1111/ijlh.13728. Epub 2021 Oct 8.
4
A machine learning PROGRAM to identify COVID-19 and other diseases from hematology data.一种用于从血液学数据中识别新冠病毒疾病和其他疾病的机器学习程序。
Future Sci OA. 2021 Jun 12;7(7):FSO733. doi: 10.2144/fsoa-2020-0207. eCollection 2021 Aug.
5
The Mechanisms and Animal Models of SARS-CoV-2 Infection.新型冠状病毒（SARS-CoV-2）感染的机制与动物模型
Front Cell Dev Biol. 2021 Apr 27;9:578825. doi: 10.3389/fcell.2021.578825. eCollection 2021.
本文引用的文献
1
Protocol for Prevention and Control of COVID-19 (Edition 6).新型冠状病毒肺炎防控方案（第六版）
China CDC Wkly. 2020 May 8;2(19):321-326. doi: 10.46234/ccdcw2020.082.
2
The trinity of COVID-19: immunity, inflammation and intervention.COVID-19 的三位一体：免疫、炎症和干预。
Nat Rev Immunol. 2020 Jun;20(6):363-374. doi: 10.1038/s41577-020-0311-8. Epub 2020 Apr 28.
3
SARS-CoV-2: a new aetiology for atypical lymphocytes.严重急性呼吸综合征冠状病毒2型：非典型淋巴细胞的一种新病因。
Br J Haematol. 2020 Jun;189(5):845. doi: 10.1111/bjh.16730. Epub 2020 May 14.
4
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.新型冠状病毒病 2019 患者的 SARS-CoV-2 抗体反应。
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034. doi: 10.1093/cid/ciaa344.
5
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
6
Functional exhaustion of antiviral lymphocytes in COVID-19 patients.新冠病毒肺炎患者抗病毒淋巴细胞的功能耗竭
Cell Mol Immunol. 2020 May;17(5):533-535. doi: 10.1038/s41423-020-0402-2. Epub 2020 Mar 19.
7
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
9
Coronavirus infections and immune responses.冠状病毒感染与免疫应答。
J Med Virol. 2020 Apr;92(4):424-432. doi: 10.1002/jmv.25685. Epub 2020 Feb 7.
10
Sensitivity and specificity of the high fluorescent lymphocyte count-gate on the Sysmex XE-5000 hematology analyzer for detection of peripheral plasma cells.Sysmex XE-5000 血液分析仪高荧光性淋巴细胞门控检测外周血浆细胞的灵敏度和特异性。
Clin Chem Lab Med. 2011 Apr;49(4):685-8. doi: 10.1515/CCLM.2011.100. Epub 2011 Mar 2.
Zotero 插件